Moderna has requested the U.S. Food and Drug Administration (FDA) to grant an emergency use authorization (EUA) for its COVID-19 vaccine for children as young as 6 months. However, according to Dr. Peter McCullough, such authorization shouldn’t be granted because there’s almost no clinical benefit for children that young.
Pfizer is also working on data for a three-dose regimen after the FDA postponed its decision in February on whether to authorize its COVID-19 vaccine for this age group.
“I think for children that age, it’s a non-starter,” McCullough told NTD’s “Capitol Report” program on April 30.
McCullough said a recent study from New York State showed the efficacy of Pfizer’s COVID-19 vaccine in young children was so low that “it looks like they don’t work.”
… » Read full article
Bombshell Study – Popular Cooking Staple Linked to Memory Loss?
Aluminum Foil Is a Major Source of Aluminum Exposure, Studies Show Analysis by Dr. Joseph Mercola – November 06, 2024 Admin Note: foil is a staple for many and
